In new independent research reports released early this morning,
Capital Review released its latest key findings for all current
investors, traders, and shareholders of Lincoln National
Corporation (NYSE:LNC), Zayo Group Holdings, Inc. (NYSE:ZAYO), AVEO
Pharmaceuticals, Inc. (NASDAQ:AVEO), NV5 Global, Inc.
(NASDAQ:NVEE), WillScot Corporation (NASDAQ:WSC), and Capstone
Turbine Corporation (NASDAQ:CPST), including updated fundamental
summaries, consolidated fiscal reporting, and fully-qualified
certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
LNC DOWNLOAD: http://Capital-Review.com/register/?so=LNC
ZAYO DOWNLOAD: http://Capital-Review.com/register/?so=ZAYO AVEO
DOWNLOAD: http://Capital-Review.com/register/?so=AVEO NVEE
DOWNLOAD: http://Capital-Review.com/register/?so=NVEE WSC DOWNLOAD:
http://Capital-Review.com/register/?so=WSC CPST DOWNLOAD:
http://Capital-Review.com/register/?so=CPST
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Capital Review,
available for free download at the links above, examine Lincoln
National Corporation (NYSE:LNC), Zayo Group Holdings, Inc.
(NYSE:ZAYO), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), NV5 Global,
Inc. (NASDAQ:NVEE), WillScot Corporation (NASDAQ:WSC), and Capstone
Turbine Corporation (NASDAQ:CPST) on a fundamental level and
outlines the overall demand for their products and services in
addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts
from the recently released reports are available to today's readers
below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. Percentage
calculations are performed after rounding. All amounts in millions
(MM), except per share amounts.
-----------------------------------------
LINCOLN NATIONAL CORPORATION (LNC) REPORT
OVERVIEW
Lincoln National's Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Lincoln National reported revenue of
$4,531.00MM vs $3,669.00MM (up 23.49%) and analysts estimated basic
earnings per share $1.89 vs $3.70 (down 48.92%). For the twelve
months ended December 31st, 2018 vs December 31st, 2017, Lincoln
National reported revenue of $16,424.00MM vs $14,257.00MM (up
15.20%) and analysts estimated basic earnings per share $7.60 vs
$9.36 (down 18.80%). Analysts expect earnings to be released on May
1st, 2019. The report will be for the fiscal period ending March
31st, 2019. The reported EPS for the same quarter last year was
$1.97. The estimated EPS forecast for the next fiscal year is
$10.09 and is expected to report on February 5th, 2020.
To read the full Lincoln National Corporation (LNC) report,
download it here:
http://Capital-Review.com/register/?so=LNC
-----------------------------------------
ZAYO GROUP HOLDINGS, INC. (ZAYO) REPORT
OVERVIEW
Zayo Group's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Zayo Group reported revenue of $639.10MM vs
$653.10MM (down 2.14%) and analysts estimated basic earnings per
share $0.13 vs $0.05 (up 160.00%). For the twelve months ended June
30th, 2018 vs June 30th, 2017, Zayo Group reported revenue of
$2,604.00MM vs $2,199.80MM (up 18.37%) and analysts estimated basic
earnings per share $0.41 vs $0.35 (up 17.14%). Analysts expect
earnings to be released on May 9th, 2019. The report will be for
the fiscal period ending March 31st, 2019. Reported EPS for the
same quarter last year was $0.09. The estimated EPS forecast for
the next fiscal year is $0.72 and is expected to report on August
28th, 2019.
To read the full Zayo Group Holdings, Inc. (ZAYO) report,
download it here:
http://Capital-Review.com/register/?so=ZAYO
-----------------------------------------
AVEO PHARMACEUTICALS, INC. (AVEO) REPORT
OVERVIEW
AVEO Pharmaceuticals' Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, AVEO Pharmaceuticals reported revenue of
$1.48MM vs $0.08MM (up 1,708.54%) and analysts estimated basic
earnings per share $0.19 vs $0.03 (up 533.33%). For the twelve
months ended December 31st, 2018 vs December 31st, 2017, AVEO
Pharmaceuticals reported revenue of $5.41MM vs $7.58MM (down
28.63%) and analysts estimated basic earnings per share -$0.04 vs
-$0.61. Analysts expect earnings to be released on May 14th, 2019.
The report will be for the fiscal period ending March 31st, 2019.
Reported EPS for the same quarter last year was -$0.08. The
estimated EPS forecast for the next fiscal year is -$0.13 and is
expected to report on March 12th, 2020.
To read the full AVEO Pharmaceuticals, Inc. (AVEO) report,
download it here:
http://Capital-Review.com/register/?so=AVEO
-----------------------------------------
NV5 GLOBAL, INC. (NVEE) REPORT OVERVIEW
NV5 Global's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, NV5 Global reported revenue of $115.34MM vs
$93.98MM (up 22.74%) and basic earnings per share $0.64 vs $1.13
(down 43.36%). For the twelve months ended December 31st, 2018 vs
December 31st, 2017, NV5 Global reported revenue of $418.08MM vs
$333.03MM (up 25.54%) and analysts estimated basic earnings per
share $2.44 vs $2.36 (up 3.39%). Analysts expect earnings to be
released on May 2nd, 2019. The report will be for the fiscal period
ending March 31st, 2019. The reported EPS for the same quarter last
year was $0.59. The estimated EPS forecast for the next fiscal year
is $4.27 and is expected to report on March 5th, 2020.
To read the full NV5 Global, Inc. (NVEE) report, download it
here:
http://Capital-Review.com/register/?so=NVEE
-----------------------------------------
WILLSCOT CORPORATION (WSC) REPORT OVERVIEW
WillScot's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, WillScot reported revenue of $257.40MM vs
$120.38MM (up 113.82%) and analysts estimated basic earnings per
share -$0.14 vs -$3.50. For the twelve months ended December 31st,
2018 vs December 31st, 2017, WillScot reported revenue of $751.41MM
vs $445.94MM (up 68.50%) and analysts estimated basic earnings per
share -$0.59 vs -$7.47. Analysts expect earnings to be released on
May 2nd, 2019. The report will be for the fiscal period ending
March 31st, 2019. The reported EPS for the same quarter last year
was $0.01. The estimated EPS forecast for the next fiscal year is
$0.71 and is expected to report on March 12th, 2020.
To read the full WillScot Corporation (WSC) report, download it
here:
http://Capital-Review.com/register/?so=WSC
-----------------------------------------
CAPSTONE TURBINE CORPORATION (CPST) REPORT
OVERVIEW
Capstone Turbine's Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Capstone Turbine reported revenue of
$18.03MM vs $22.76MM (down 20.79%) and analysts estimated basic
earnings per share -$0.05 vs -$0.01. For the twelve months ended
March 31st, 2018 vs March 31st, 2017, Capstone Turbine reported
revenue of $82.84MM vs $77.17MM (up 7.34%) and analysts estimated
basic earnings per share -$0.20 vs -$0.79. Analysts expect earnings
to be released on June 6th, 2019. The report will be for the fiscal
period ending March 31st, 2019. The reported EPS for the same
quarter last year was -$0.02. The estimated EPS forecast for the
next fiscal year is -$0.05 and is expected to report on June 6th,
2019.
To read the full Capstone Turbine Corporation (CPST) report,
download it here:
http://Capital-Review.com/register/?so=CPST
-----------------------------------------
ABOUT CAPITAL REVIEW
Capital Review is a nationally recognized
publisher of financial analysis, research reports, and exclusive
market reporting. Institutional investors, registered brokers,
professional traders, and personal investment advisers rely on
Capital Review to quantify public company valuations, discover
opportunity across asset classes, stay informed about market-moving
events, and read exclusive analysis of important material
developments. With 14 offices worldwide, Capital Review staffs and
manages certified and registered financial professionals, including
Chartered Financial Analyst® (CFA®) designation holders and FINRA®
BrokerCheck® certified individuals with current and valid CRD®
number designations, to enable continuous coverage of topics
relevant to its regular active reader base.
REGISTERED MEMBER STATUS
Capital Review's oversight and audit staff are
registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Capital Review's roster includes qualified
CFA® charterholders, licensed securities attorneys, and registered
FINRA® members holding duly issued CRD® numbers. Current licensed
status of several Registered Members at Capital Review have been
independently verified by an outside audit firm, including policy
and audit records duly executed by Registered Members. Complaints,
concerns, questions, or inquiries regarding this release should be
directed to Capital Review's Compliance department by Phone, at +1
(410) 280-7496, or by E-mail at compliance@Capital-Review.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Capital Review,
Capital Review members, and/or Capital Review affiliates are not
responsible for any gains or losses that result from the opinions
expressed. Capital Review makes no representations as to the
completeness, accuracy, or timeliness of the material provided and
all materials are subject to change without notice. Capital Review
has not been compensated for the publication of this press release
by any of the above mentioned companies. Capital Review is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Morena Zambada, Media Department
Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com
© 2019 Capital Review. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@Capital-Review.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Jun 2024 to Jul 2024
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Jul 2023 to Jul 2024